Characteristics of Gut Microbiota in Patients with Severe Pneumonia and its Potential Clinical Relevance. [PDF]
Zhong F, Huang M, Wei X, Fu L, Yan L.
europepmc +1 more source
MiR-100-5p is involved in severe pneumonia in children by targeting MTOR. [PDF]
Zhang L, Wang Q, Mo S.
europepmc +1 more source
ROS-responsive nanogels enable inhaled CD24 immunotherapy for selective hyperinflammation suppression in severe pneumonia. [PDF]
Wang X +7 more
europepmc +1 more source
Ventilatory Parameters and Adjunctive Therapies Associated with ICU Mortality in Severe Pneumonia: A Large Retrospective Cohort Study. [PDF]
Nie W, Guo J, Tang N, Liang Z, Zhou Y.
europepmc +1 more source
Clinical significance of LINC01093 in children with severe pneumonia and its regulation of miR‑326/MAPK1 axis. [PDF]
Tong P, Wang N.
europepmc +1 more source
Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes. [PDF]
Jeffrey M +22 more
europepmc +1 more source
Characteristics of <i>Chlamydia pneumoniae</i> infection in 141 children with respiratory tract infection and risk factors for severe pneumonia. [PDF]
Li S, Chen L, Liu H.
europepmc +1 more source
Awake VV-ECMO for severe pneumonia caused by Elizabethkingia anophelis: a case report. [PDF]
Guanglin W, Xiuwen K, Rong H.
europepmc +1 more source
Comparative study of piperacillin-tazobactam versus ampicillin in the treatment of severe pneumonia in children: A retrospective study. [PDF]
Wang J, Cao J, Zhang L.
europepmc +1 more source
Clinical characteristics and risk factors of necrotizing pneumonia secondary to severe pneumonia in children. [PDF]
Che L, Zhou W, Chen Q, Cheng F, Tian J.
europepmc +1 more source

